Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/6F9D52AE.svg?ark=w1%2F20260515%2F6F9D52AE)](https://nobleid.org/work/w1/20260515/6F9D52AE)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors